Document is current
Any future updates will be listed below
-
Authors
Kelly, Patrick H.
Kwark, Rob
Marick, Harrison M.
Davis, Julie
Stark, James H.
Madhava, Harish
Dobler, Gerhard
Moïsi, Jennifer C.
- License Information
-
More Information
Article History
Received: 15 September 2024
Accepted: 20 February 2025
First Online: 14 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: PHK, JHS, HM, and JCM are employees of Pfizer and may hold shares and/or stock options in the company. RK and HMM are employees of Tiber Solutions, which received funding from Pfizer in connection with the development of this manuscript. JD is an employee of Clarivate Analytics, which received funding from Pfizer in connection with the development of this manuscript. GD was a paid contractor to Pfizer in connection with the development of this manuscript. Pfizer owns a tick-borne encephalitis vaccine (FSME-IMMUN© / Ticovac©). Part of this work was supported and jointly funded by Valneva and Pfizer as part of their co-development of a Lyme Disease vaccine.
